Effects of prolonging peak dobutamine dose during stress echocardiography

Journal of the American College of Cardiology

Volumn 29, Issue 3, 1997, Pages 526-530

  Weissman, Neil J ^a   Rose, Geoffrey A ^b   Foster, Gary P ^b   Picard, Michael H ^b  

^a GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATROPINE; DOBUTAMINE;

ADULT; AGED; ARTICLE; ELECTROCARDIOGRAM; FEMALE; HEART ARRHYTHMIA; HEART FUNCTION; HEART RATE; HUMAN; HYPOTENSION; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; STRESS;

EID: 0030894340     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(96)00558-X     Document Type: Article

References (24)

1. Mertes H, Sawada SG, Ryan T, et al. Symptoms, adverse effects and complications associated with dobutamine stress echocardiography: experience in 1118 patients. Circulation 1993;88:15-9.
2. Akosah KO, Porter TR, Simon R, Funai JT, Minisi AJ, Mohanty PK Ischemia-induced regional wall motion abnormality is improved after coronary angioplasty: demonstration by dobutamine stress echocardiography. J Am Coll Cardiol 1993;21:584-9.
3. Kates RE, Leier CV. Dobutamine pharmacokinetics in severe heart failure. Clin Pharmacol Ther 1978;24:537-41.
4. Tuttle RR, Mills J. Development of a new catecholamine to selectively increase cardiac contractility. Circ Res 1975;36:185-96.
5. Weissman NJ, Nidorf SM, Guerrero JL, Weyman AE, Picard MH. Optimal stage duration in dobutamine stress echocardiography. J Am Coll Cardiol 1995;25:605-9.
6. Smart SC, Sawada S, Ryan T, et al. Low-dose dobutamine echocardiography detects reversible dysfunction after thrombolytic therapy of acute myocardial infarction. Circulation 1993;88:405-15.
7. Pierard LA, DeLandsheere CM, Berthe C, Rigo P, Kulbertus HE. Identification of viable myocardium by echocardiography during dobutamine infusion in patients with myocardial infarction after thrombolytic therapy: comparison with positron emission tomography. J Am Coll Cardiol 1990;15: 1021-31.
8. Watada H, Ito H, Oh H, et al. Dobutamine stress echocardiography predicts reversible dysfunction and quantitates the extent of irreversibly damaged myocardium after reperfusion of anterior myocardial infarction. J Am Coll Cardiol 1994;24:624-30.
9. Marwick T, D'Hondt AM, Baudhuin T, et al. Optimal use of dobutamine stress for the detection and evaluation of coronary artery disease: Combination with echocardiography, scintigraphy or both? J Am Coll Cardiol 1993;22:159-67.
10. Daoud EG, Pitt A, Armstrong WF. Electrocardiographic response during dobutamine stress echocardiography. Am Heart J 1995;129:672-7.
11. Mazeika PK, Nadazdin A, Oakley CM. Dobutamine stress echocardiography for detection and assessment of coronary artery disease. J Am Coll Cardiol 1992;19:1203-11.
12. Gordon BM, Mohan V, Chapekis AT, et al. An analysis of the safety of performing dobutamine stress echocardiography in an ambulatory setting. J Am Soc Echocardiogr 1995;8:15-20.
13. McNeill AJ, Fioretti PM, El-Said EM, Salustri A, Forster T, Roelandt JRTC. Enhanced sensitivity for detection of coronary artery disease by addition of atropine to dobutamine stress echocardiography. Am J Cardiol 1992;70: 41-6.
14. Weissman NJ, Levangie MW, Guerrero JL, Weyman AE, Picard MH. The effect of beta blockade on dobutamine stress echocardiography. Am Heart J 1996;131:698-703.
15. Lumley P, Broadley KJ. Evidence from agonist and antagonist studies to suggest that the betal-adrenoceptors subserving the positive inotropic and chronotropic responses of the heart do not belong to two separate sub-groups. J Pharm Pharmacol 1977;29:598-604.
16. Lumley P, Broadley KJ, Levy GP. Analysis of the inotropic-chronotropic selectivity of dobutamine and dopamine in anaesthetized dogs and guinea-pig isolated atria. Cardiovasc Res 1977;11:17-25.
17. Daly AL, Linares OA, Smith MJ, Starling MR, Supiano MA. Dobutamine pharmacokinetics during dobutamine stress echocardiography [abstract]. Circulation 1995;92 Suppl 1:1-88.
18. Poldermans D, Fioretti PM, Sciarra A, et al. Catecholamine responses of two different dobutamine infusion protocols, continuous low dose vs stepwise increment [abstract]. Circulation 1995;92 Suppl 1:1-478.
19. Benvenisty AI, Spotnitz HM, Rose EA, Malm JR, Hoffman BF. Antagonism of chronic canine beta-adrenergic blockade with dopamine-isoproterenol, dobutamine and glucagon. Surg Forum 1979;30:187-8.
20. Waagstein F, Malek I, Hjalmarson AC. The use of dobutamine in myocardial infarction for reversal of the cardiodepressive effect of metoprolol. Br J Clin Pharmacol 1978;5:515-21.
21. Das G. Cardiac effects of atropine in man: an update. Int J Clin Pharmacol Ther Toxicol 1989;27:473-7.
22. Ling LH, Pellikka PA, Mahoney DW, et al. Atropine augmentation in dobutamine stress echocardiography: role and incremental value in a clinical practice setting. J Am Coll Cardiol 1996;28:551-7.
23. Hepner AM, Bach DS, Armstrong WF. Early chronotropic incompetence predicts the need for atropine during dobutamine stress echocardiography [abstract]. J Am Coll Cardiol 1996;27 Suppl A:231A.
24. Rose GA, Weissman NJ, Foster GP, Picard MH. Comparison of arbutamine to dobutamine stress echocardiography in humans [abstract]. Circulation 1995;92 Suppl I:I-412.